Skip to content

Malignant Pleural Effusions: Evaluating the psYchosocial Impact of Indwelling Pleural Catheters on Patients

Malignant Pleural Effusions: Evaluating the psYchosocial Impact of Indwelling Pleural Catheters on Patients (MY-IPC)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05372055
Acronym
MY-IPC
Enrollment
18
Registered
2022-05-12
Start date
2022-05-09
Completion date
2023-05-08
Last updated
2023-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Indwelling Pleural Catheter, Malignant Pleural Effusion

Keywords

Malignant Pleural Effusion, Indwelling Pleural Catheter, Psychosocial

Brief summary

The purpose of this study is to better understand the impact that Indwelling Pleural Catheters have on patients with malignant pleural effusions from a psychosocial point of view.

Detailed description

After being informed about the study, all patients giving written informed consent will undergo a baseline assessment including disease and social characteristics on the day of their Indwelling Pleural Catheter (IPC) insertion. At 2 weeks and 6-8 weeks post insertion, they will be contacted via telephone for a semi-structured interview focusing on the psychosocial impact that the IPC has had on their lives. Data surrounding the medical care of the IPC will also be collected.

Interventions

Semi-structured interview focusing on psychosocial impact of living with an IPC to be performed at 2 weeks and 6-8 weeks post IPC insertion

Sponsors

Guy's and St Thomas' NHS Foundation Trust
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participant is willing and able to give informed consent for participation in the study * Aged 18 years or above * Diagnosis of malignant pleural effusion * Will be undergoing IPC insertion for management of their malignant pleural effusion * Have the means to be contacted and be able to conduct an interview in English via telephone within the study timeframe

Exclusion criteria

* Inability to consent * Estimated life expectancy of \<4 weeks

Design outcomes

Primary

MeasureTime frameDescription
The psychosocial impact of living with an indwelling pleural catheter in patients with malignant pleural effusions2 weeksQualitative data

Secondary

MeasureTime frameDescription
Links between psychosocial impact experienced by patients and their baseline, disease or social characteristics2 weeks and 6-8 weeksQualitative data
Links between psychosocial impact experienced by patients and their IPC care characteristics2 weeks and 6-8 weeksQualitative data

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026